A2M-AS1 Gene

Name A2M antisense RNA 1 (head to head)
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The long non‐coding RNA A2M‑AS1 has emerged as a multifunctional regulator in diverse human diseases. In breast cancer, for instance, A2M‑AS1 is notably upregulated and its increased expression correlates with aggressive tumor phenotypes (ER‑negative, HER2‑positive, basal‑like) as well as poor recurrence‑free and metastasis‑free survival. Mechanistic studies in breast cancer further suggest that A2M‑AS1 promotes cell proliferation, invasion, and migration by modulating downstream factors in the cell adhesion molecule pathway and by acting as a molecular sponge for microRNAs (e.g. miR‑146b) to upregulate targets such as MUC19 and consequently alter Hippo signaling ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]."}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the context of myocardial ischemia/reperfusion injury, A2M‑AS1 appears to play a protective role. Its expression is downregulated in hypoxia/reoxygenation‑induced cardiomyocytes, and forced overexpression rescues cell viability while reducing apoptosis and oxidative stress. This cardioprotective function has been attributed to the regulation of the A2M‑AS1/IL1R2 axis as well as to exosomal delivery of A2M‑AS1 that modulates miR‑556‑5p/XIAP signaling ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "]."}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In several cancers, including gastric cancer, non‑small cell lung cancer, and lung adenocarcinoma, A2M‑AS1 has been identified as a hub long non‑coding RNA within competing endogenous RNA networks and co‑expression analyses, associating its dysregulated expression with tumor progression and overall survival; similarly, aberrant DNA methylation at the A2M‑AS1 locus has been linked to increased breast cancer risk following exposure to environmental toxicants ["}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "9"}]}, {"type": "t", "text": "].\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Additional studies have implicated A2M‑AS1 in noncancerous conditions as well. In chronic obstructive pulmonary disease, interaction networks involving A2M‑AS1 (together with miR‑122‑5p and other lncRNAs) may contribute to the disease’s pathogenesis irrespective of smoking status, and in myocardial infarction, A2M‑AS1 has been identified as a potential biomarker for predicting recurrence ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "]. Moreover, in pancreatic ductal adenocarcinoma, A2M‑AS1 is emerging as a prognostic biomarker that might offer new avenues for early diagnosis and targeted therapy ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "]. \n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings highlight that A2M‑AS1 plays critical, context‑dependent roles—functioning as either an oncogenic driver or a protective factor—thereby representing a promising diagnostic, prognostic, and therapeutic target across multiple disease settings.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kai Fang, Hu Caixia, Zhang Xiufen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Screening of a Novel Upregulated lncRNA, A2M-AS1, That Promotes Invasion and Migration and Signifies Poor Prognosis in Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/9747826"}], "href": "https://doi.org/10.1155/2020/9747826"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32352014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32352014"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yuncong Liu, Qi Zhang, Jing Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Non-Coding RNA A2M-AS1 Promotes Breast Cancer Progression by Sponging microRNA-146b to Upregulate MUC19."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gen Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/IJGM.S278564"}], "href": "https://doi.org/10.2147/IJGM.S278564"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33273850"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33273850"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xue-Lian Song, Fei-Fei Zhang, Wen-Jing Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA A2M-AS1 lessens the injury of cardiomyocytes caused by hypoxia and reoxygenation via regulating IL1R2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Genomics (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13258-020-01007-6"}], "href": "https://doi.org/10.1007/s13258-020-01007-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33057899"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33057899"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hang Yu, Yuxiang Pan, Mingming Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesenchymal Stem Cell-Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Drugs Ther (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10557-022-07339-7"}], "href": "https://doi.org/10.1007/s10557-022-07339-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35543792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35543792"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Lianmin Ye, Wumin Jin "}, {"type": "b", "children": [{"type": "t", "text": "Identification of lncRNA-associated competing endogenous RNA networks for occurrence and prognosis of gastric carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Lab Anal (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcla.24028"}], "href": "https://doi.org/10.1002/jcla.24028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34704289"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34704289"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Fei He, Liping Huang, Qiuping Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.3369"}], "href": "https://doi.org/10.1002/cam4.3369"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32869486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32869486"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Peng Cao, Fan Li, Yajie Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/5118444"}], "href": "https://doi.org/10.1155/2022/5118444"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35237359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35237359"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yuan Chun Ding, Susan Hurley, June-Soo Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation biomarkers of polybrominated diphenyl ethers (PBDEs) and association with breast cancer risk at the time of menopause."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.envint.2021.106772"}], "href": "https://doi.org/10.1016/j.envint.2021.106772"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34425644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34425644"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Wenyong Zhou, Tao Liu, Gaowa Saren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive analysis of differentially expressed long non-coding RNAs in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Lett (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ol.2019.10414"}], "href": "https://doi.org/10.3892/ol.2019.10414"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31423174"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31423174"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yan Qian, Zheng-Dao Mao, Yu-Jia Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive Analysis of miRNA-mRNA-lncRNA Networks in Non-Smoking and Smoking Patients with Chronic Obstructive Pulmonary Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000494541"}], "href": "https://doi.org/10.1159/000494541"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30355907"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30355907"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Linlin Qiu, Xueqing Liu "}, {"type": "b", "children": [{"type": "t", "text": "Identification of key genes involved in myocardial infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Med Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40001-019-0381-x"}], "href": "https://doi.org/10.1186/s40001-019-0381-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31269974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31269974"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Matteo Giulietti, Alessandra Righetti, Giovanni Principato, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgy069"}], "href": "https://doi.org/10.1093/carcin/bgy069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29796634"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29796634"}]}]}]}
NCBI Gene ID 144571
API
Download Associations
Predicted Functions View A2M-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View A2M-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View A2M-AS1's ARCHS4 Predicted Functions.

Functional Associations

A2M-AS1 has 720 functional associations with biological entities spanning 3 categories (chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.

Click the + buttons to view associations for A2M-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of A2M-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of A2M-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of A2M-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of A2M-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of A2M-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of A2M-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of A2M-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of A2M-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of A2M-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of A2M-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of A2M-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of A2M-AS1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.